B-cell Lymphomas

1

Review clinical trials related to B-cell Lymphomas. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas

To find the highest tolerable dose of JV-213 (a type of autologous CAR T cell therapy) that can be given to patients who have B-cell lymphoma that is relapsed or refractory.

Participants needed: 33
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: May 18, 2026Locations: 1
Eligibility criteria

For the dose escalation cohort: Eligible patients will include those with r/r B-... [+16]

Active central nervous system (CNS) lymphoma including patients with detectable... [+18]